TLR7/8 agonist 3
CAS No. 642473-95-8
TLR7/8 agonist 3( —— )
Catalog No. M26483 CAS No. 642473-95-8
TLR7/8 agonist 3 is a potent agonist of TLR7 and TLR8.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 150 | In Stock |
|
| 5MG | 136 | In Stock |
|
| 10MG | 226 | In Stock |
|
| 25MG | 368 | In Stock |
|
| 50MG | 498 | In Stock |
|
| 100MG | 686 | In Stock |
|
| 200MG | 923 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTLR7/8 agonist 3
-
NoteResearch use only, not for human use.
-
Brief DescriptionTLR7/8 agonist 3 is a potent agonist of TLR7 and TLR8.
-
DescriptionTLR7/8 agonist 3 is a potent agonist of TLR7 and TLR8.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetTLR
-
RecptorSMARCA2| SMARCA4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number642473-95-8
-
Formula Weight313.405
-
Molecular FormulaC17H23N5O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (159.54 mM)
-
SMILESCCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wanior M, et, al. Pan-SMARCA/PB1 Bromodomain Inhibitors and Their Role in Regulating Adipogenesis. J Med Chem. 2020 Dec 10;63(23):14680-14699.
molnova catalog
related products
-
Tomaralimab
Tomaralimab (OPN-305) is a humanized IgG4 monoclonal antibody targeting TLR2, used to study myelodysplastic syndromes (MDS).
-
TLR7/8 agonist 1
TLR7/8 agonist 1 is a toll-like receptor TLR7/TLR8 agonist with anticancer and antiviral activities and can be used to study immune-related diseases.
-
EPZ020411 2HCl
EPZ020411 is an effective and specific small molecule PRMT6 inhibitor (IC50=10 nM).
Cart
sales@molnova.com